Skip to main content
Account

Table 1 Pharmacokinetic parameters of the intravenous solution and intravenous nanosuspension doses

From: Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment

Parameter

Solution dose (n = 3)

Nanosuspension dose (n = 4)

Route

Intravenous

Intravenous

Target dose (mg/kg)

3.0

2.5

C 0(μg/mL)

2.5 ± 0.1

2.0 ± 0.2

t 1/2α(h)

0.4 ± 0.1

0.4 ± 0.1

t 1/2β(h)

3.9 ± 0.6

4.8 ± 0.9

V ss(mL/kg)

2100 ± 130

3000 ± 530

CL (mL/min/kg)

33.6 ± 0.9

35 ± 1.0

MRT (h)

1.1 ± 0.1

1.5 ± 0.4

AUC0–∞(μg h/mL)

1.5 ± 0.1

1.2 ± 0.1

Mean AUC0–∞(μg h/mL)/dose

0.5

0.5

Navigation